In mid-January, the Centers for Disease Control and Prevention (CDC) released an updated version of its Antibiotic Resistance Map, which illustrates the CDC’s efforts both within the U.S. and abroad to help local health officials battle resistance.
“We have found that deep-sea microorganisms, especially actinomycetes, are an attractive, untapped source for the discovery of anti-infective agents,” said Guojun Wang, Ph.D., assistant research professor at FAU Harbor Branch.
The aim of a recent study lead by researchers at the University of Lyon was to evaluate the performance of a multiplex molecular testing platform based on rapid polymerase chain reaction (PCR).
Never Miss a Post!
- Acute and Intensive Care
- Antibiotic Resistance
- Antimicrobial Resistance
- Antimicrobial Stewardship
- Book Reviews
- Carbapenem-Resistant Enterobacteriaceae (CRE)
- Case Studies
- Clostridium difficile (C. difficile)
- Compliance Standards
- Cystic Fibrosis
- Drugs and Drug Efficacy